1Robinson M, Horn J. Clinical pharmacology of proton pump inhibitors : What the practising physician needs to know [ J ]. Drugs,2003 ;63(24) :2739 -2754. 被引量：1
2Robinson M, pH, healing and symptom relief with rabeprazole treatment in acid-related disorders [ J ]. Aliment Pharmacol Ther, 2004 ;20 ( Suppl 6 ) : 30 - 37. 被引量：1
8Peters HD,Grymbowski T. Comparison oftherapeutic efficacy and tolerability of 30 mg lansoprazole and 40 mg famotidine in patients with uncomplicated gastric ulcer: A multicentre, ran- domized,double-blind, parallel trial. TAP report PD-1082, vol 1 16; study KF 4801/07, 1990. TAP Pharmaceuticals, Inc., Deerfield, Ill. 被引量：1
9Okai T, Sawabu N, Songur Y, et alal Comparison of lansoprazole arid famotidine for gastric ulcer by endoscopic ultrasonography a prelinfinary trial [J]. J 'Clin Gastroenterol, 1995, 20 (Suppl 2):32- 35. 被引量：1
10Sakaguchi N, Ashida K, Umegaki E, et al. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers= Comparison with famotidine[ J]. J Clin Gastroenterol, 1995,20 (Suppl 2) :27 -31. 被引量：1
